Story perspectives
Beta Blockers May Slow Aggressive Breast Cancer Progression
8/22/2025
50 8
1 of 1
Story summary
- A Monash University study indicates beta blockers may slow triple negative breast cancer progression by inhibiting the HOXC12 gene.
- This research expands on 2023 findings that linked beta blockers to lower mortality rates in affected patients.
- Further research is necessary to identify patients who could benefit from this affordable treatment.
- Triple negative breast cancer is aggressive, with a 12% survival rate for advanced cases.
